A Study to Evaluate the Safety and Effectiveness of Mirogabalin in Chinese Adult Patients With Diabetic Peripheral Neuropathic Pain (DPNP) in Real-world Clinical Practice Setting (ReMIssion Study)

NCT06812117 · clinicaltrials.gov ↗

ACTIVE_NOT_RECRUITING

Status

721

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Peripheral Neuropathic Pain

Interventions

OTHER: No Drug

Sponsor

Daiichi Sankyo